A late-stage clinical trial was conducted by Biogen and Eisai and the new Alzheimer’s drug they are developing for Alzheimer’s disease slowed the rate of cognitive decline. New Alzheimer’s Drug …
Research Study Shows New Alzheimer’s Drug Slows Cognitive Decline Read More »
Article was written by South Florida Hospital News and Healthcare Report Adam and Monica Adache knew something wasn’t right when their daughter, Maya, had a seizure at only six months …
Early Intervention Provides Hope to Children Diagnosed with Epilepsy Read More »
We are enthusiastic about the results of the BAN2401 phase 2 clinical trial for dementia. The study assessed changes from baseline to 18 months in biomarkers measuring the underlying disease …
BAN2401 Phase 3 Clinical Trial Starting April 2019 Read More »
